Overview

Zinc Supplementation in Pediatric Sepsis

Status:
Active, not recruiting
Trial end date:
2022-08-01
Target enrollment:
0
Participant gender:
All
Summary
a single blinded randomized controlled clinical trial that was conducted to evaluate the role of zinc supplementation in improving the outcome of infants and children with sepsis in pediatric intensive care unit.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Mansoura University
Treatments:
Zinc Sulfate
Criteria
Inclusion Criteria:

- 2- Pediatric patients who fulfill Pediatric Consensus criteria for definition of
severe sepsis as 1) greater than or equal to 2 age-based systemic inflammatory
response syndrome criteria, 2) confirmed or suspected invasive infection, and 3)
cardiovascular dysfunction, acute respiratory distress syndrome, or greater than or
equal to 2 organ system dysfunctions

Exclusion Criteria:

- Infants and children with history of prematurity (< 37 weeks), chronic cardiopulmonary
disease, immunodeficiency, neuromuscular disease, surgical conditions and any other
chronic medical condition.

- Those who are regularly taking vitamin or mineral supplementations